Suppr超能文献

纯腹腔镜肝切除术与开腹肝切除术治疗肝细胞癌的长期围手术期结局:一项回顾性研究。

Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study.

机构信息

Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, South Korea.

出版信息

Surg Endosc. 2020 Feb;34(2):796-805. doi: 10.1007/s00464-019-06831-w. Epub 2019 Jun 3.

Abstract

BACKGROUND

Laparoscopic treatment for hepatocellular carcinoma (HCC) has increased. We retrospectively compared the perioperative and long-term oncological outcomes of laparoscopic liver resection (LLR) with those of open liver resection (OLR) for hepatocellular carcinoma (HCC) in well-matched patient groups using propensity score matching (PSM).

METHODS

We reviewed medical records of patients with HCC who underwent liver resection between July 2007 and April 2016 at our center. In total, 2335 patients were included in this study and divided into LLR (n = 264) and OLR (n = 2071) groups. For group comparisons, 1:2 PSM was used with covariates of baseline characteristics, including tumor characteristics and surgical liver resection procedures.

RESULTS

After PSM, there were 217 and 434 patients in the LLR and OLR groups, respectively. The LLR group had shorter hospital stays (8.9 vs. 14.8 days; P < 0.001) and lower postoperative morbidity (6.5% vs. 12.0%; P = 0.022). The 1-, 3-, and 5-year overall survival rates were 98.1%, 87.0%, and 78.6%, respectively, for the LLR group, and 98.3%, 90.8%, and 84.3%, respectively, for the OLR group (P = 0.570). The 1-, 3-, and 5-year disease-free survival rates were 81.0%, 62.0%, and 49.1%, respectively, for the LLR group, and 85.3%, 64.7%, and 56.2%, respectively, for the OLR group (P = 0.563).

CONCLUSIONS

Long-term oncological outcomes were comparable between LLR and OLR for selected patients. LLR was associated with multiple benefits, even for selected patients with cirrhosis who underwent major hepatectomy. LLR for HCC performed by an experienced surgeon could be considered a safe and feasible alternative to OLR for selected patients.

摘要

背景

腹腔镜治疗肝细胞癌(HCC)的应用有所增加。我们使用倾向评分匹配(PSM)比较了腹腔镜肝切除术(LLR)与开腹肝切除术(OLR)治疗匹配良好的肝细胞癌患者的围手术期和长期肿瘤学结果。

方法

我们回顾性分析了 2007 年 7 月至 2016 年 4 月在我院接受肝切除术的 HCC 患者的病历。共有 2335 例患者纳入本研究,分为 LLR(n=264)和 OLR(n=2071)组。为了进行组间比较,我们使用了包括肿瘤特征和手术肝脏切除程序在内的基线特征的 1:2 PSM。

结果

PSM 后,LLR 和 OLR 组分别有 217 例和 434 例患者。LLR 组的住院时间更短(8.9 天 vs. 14.8 天;P<0.001),术后发病率更低(6.5% vs. 12.0%;P=0.022)。LLR 组的 1、3 和 5 年总生存率分别为 98.1%、87.0%和 78.6%,OLR 组分别为 98.3%、90.8%和 84.3%(P=0.570)。LLR 组的 1、3 和 5 年无病生存率分别为 81.0%、62.0%和 49.1%,OLR 组分别为 85.3%、64.7%和 56.2%(P=0.563)。

结论

对于选定的患者,LLR 与 OLR 的长期肿瘤学结果相当。LLR 与多种益处相关,甚至对接受大范围肝切除术的肝硬化患者也是如此。对于选定的患者,由经验丰富的外科医生进行的 HCC LLR 可被视为 OLR 的一种安全且可行的替代方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验